Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non–small cell lung cancer

National Comprehensive Cancer Network, 2018 DeCamp, 2003, Value of accelerated multimodality therapy in stage IIIA and IIIB non–small cell lung cancer, J Thorac Cardiovasc Surg, 126, 17, 10.1016/S0022-5223(03)00206-X Ichinose, 2003, Induction chemoradiotherapy and surgical resection for selected stage IIIB non–small-cell lung cancer, Ann Thorac Surg, 76, 1810, 10.1016/S0003-4975(03)01075-0 Stupp, 2009, Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial, Lancet Oncol, 10, 785, 10.1016/S1470-2045(09)70172-X Grunenwald, 2001, Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non–small cell lung cancer, J Thorac Cardiovasc Surg, 122, 796, 10.1067/mtc.2001.116472 Stamatis, 1999, Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results, Ann Thorac Surg, 68, 1144, 10.1016/S0003-4975(99)00976-5 Weiden, 1994, Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer. A phase 2 study of the LCSG, Chest, 106, 344S Pitz, 2002, Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer, Ann Thorac Surg, 74, 164, 10.1016/S0003-4975(02)03647-0 Albain, 2002, Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non–small-cell lung cancer: a Southwest Oncology Group Phase II Study, SWOG 9019, J Clin Oncol, 20, 3454, 10.1200/JCO.2002.03.055 Rusch, 1993, Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial, J Thorac Cardiovasc Surg, 105, 97, 10.1016/S0022-5223(19)33853-X Albain, 2009, Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial, Lancet, 374, 379, 10.1016/S0140-6736(09)60737-6 Bott, 2015, Role for surgical resection in the multidisciplinary treatment of stage IIIB non–small cell lung cancer, Ann Thorac Surg, 99, 1921, 10.1016/j.athoracsur.2015.02.033 Galetta, 2003, Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach, Ann Thorac Surg, 76, 1802, 10.1016/S0003-4975(03)01063-4 Takeda, 2006, Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA–IIIB) lung cancer, Eur J Cardiothorac Surg, 30, 184, 10.1016/j.ejcts.2006.03.054 Bilimoria, 2008, The National Cancer Data Base: a powerful initiative to improve cancer care in the United States, Ann Surg Oncol, 15, 683, 10.1245/s10434-007-9747-3 Austin, 2009, Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples, Stat Med, 28, 3083, 10.1002/sim.3697 Harrell, 2015, Multivariable modeling strategies Li, 2015, Statistical inference methods for two crossing survival curves: a comparison of methods, PLoS ONE, 10, e0116774, 10.1371/journal.pone.0116774 Albain, 1995, Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non–small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805, J Clin Oncol, 13, 1880, 10.1200/JCO.1995.13.8.1880 Krantz, 2018, Invasive mediastinal staging for lung cancer by the Society of Thoracic Surgeons Database participants, Ann Thorac Surg, 106, 1055, 10.1016/j.athoracsur.2018.05.012 Thornblade, 2018, Variability in invasive mediastinal staging for lung cancer: a multicenter regional study, J Thorac Cardiovasc Surg, 155, 2658, 10.1016/j.jtcvs.2017.12.138 Antonia, 2018, Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC, N Engl J Med, 379, 2342, 10.1056/NEJMoa1809697 Antonia, 2017, Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer, N Engl J Med, 377, 1919, 10.1056/NEJMoa1709937